Starling Oncology, Inc. (DFPH) Revenue 2020–2025
Starling Oncology, Inc. (DFPH) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$502.7MFY2025 · since FY2020: $187.5M → $502.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $502.7M | +27.8% |
| FY2024 | $393.4M | +21.3% |
| FY2023 | $324.2M | +28.4% |
| FY2022 | $252.5M | +24.4% |
| FY2021 | $203.0M | +8.3% |
| FY2020 | $187.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More DFPH financial trends
DFPH Net incomeDFPH Net marginDFPH Gross profitDFPH Gross marginDFPH Operating incomeDFPH Operating marginDFPH Operating cash flowDFPH Free cash flowDFPH Capital expendituresDFPH Return on equityDFPH Stock buybacksDFPH Dividends paidDFPH Total assetsDFPH Total liabilitiesDFPH Shareholders’ equityDFPH overview →